Startup Professionals Musings
MAY 2, 2021
In that context, I came across an old study of 27 startups featured in Inc’s annual “Anatomies of a Start-up,” done for “The Journal of Business Venturing,” and published by George Gendron in Inc Magazine. As it turned out, 17 of the 27 companies were still in business seven years later, which is at least double that of other studies.
Xconomy
MARCH 17, 2017
Stung by slow sales of its next-generation anti-cholesterol drug, Amgen hopes new clinical data, released this morning, will spur doctors to boost prescriptions and—perhaps more important—drive insurers to loosen their restrictions. political issue, and pricey new cholesterol drugs have been a key battleground.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
InfoChachkie
NOVEMBER 3, 2014
As noted in this recent Wall Street Journal article, Google has begun requesting that merchants include rating and review data to ensure that the efficacy of their search results. I’ve seen some smaller retailers execute very innovative strategies, such as posting items for sale on Instagram to the first person who emails them.
Startup Professionals Musings
MAY 10, 2013
In that context, I came across an old study of 27 startups featured in Inc’s annual “Anatomies of a Start-up,” done for “The Journal of Business Venturing,” and published by George Gendron in Inc Magazine. As it turned out, 17 of the 27 companies were still in business seven years later, which is at least double that of other studies.
Xconomy
APRIL 20, 2017
Over more than two decades, Perry has studied the possibility that diseases like Alzheimer’s may get their start because the body produces too many variants of oxygen, called free radicals, which cause cell damage, and not enough antioxidants to limit the damage.
Startup Professionals Musings
APRIL 16, 2012
In that context, I recently came across an old study of 27 startups featured in Inc’s annual “Anatomies of a Start-up,” done for “The Journal of Business Venturing,” and published by George Gendron in Inc Magazine. To determine what factors made a difference, the researchers compared the 27 companies using numerous variables.
socalTECH
AUGUST 2, 2017
We have done both retrospective proof-of-concept and also prospective studies to prove out the concept, which is based on probably 100 papers worth of articles published in scientific journals. The use of the proceedshas really been about ramping up commercialization and sales. There's a lot of foundational science here.
Expert insights. Personalized for you.
170 
Let's personalize your content